Hiroshi Arima Selected Research

Vincristine (Oncovin)

12/2013	Impact of occult bone marrow involvement on the outcome of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy for diffuse large B-cell lymphoma.
1/2011	Enteropathy-associated T-cell lymphoma type II complicated by autoimmune hemolytic anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Arima Research Topics

Disease

20	Neoplasms (Cancer) 12/2023 - 07/2010
12	Diabetes Insipidus 03/2023 - 05/2009
11	Polyuria 03/2023 - 11/2008
11	Obesity 01/2021 - 10/2007
10	Hyponatremia 02/2024 - 12/2010
10	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2024 - 01/2013
10	Insulin Resistance 10/2021 - 08/2004
9	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 01/2021
9	Body Weight (Weight, Body) 01/2021 - 01/2006
7	Hypopituitarism (Sheehan's Syndrome) 01/2023 - 08/2010
7	Inflammation (Inflammations) 09/2022 - 10/2013
7	Lymphoma (Lymphomas) 01/2021 - 04/2010
6	Type 2 Diabetes Mellitus (MODY) 05/2024 - 11/2008
5	Polydipsia 03/2020 - 11/2008
4	Hypothyroidism 01/2022 - 03/2018
4	Hyperglycemia 01/2022 - 01/2015
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 12/2013
4	Dehydration (Water Stress) 11/2020 - 02/2012
3	Thyrotoxicosis 04/2024 - 11/2018
3	Demyelinating Diseases (Demyelinating Disease) 02/2024 - 12/2010
3	Inappropriate ADH Syndrome (SIADH) 10/2023 - 04/2004
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2023 - 01/2017
3	Thyroiditis 01/2022 - 03/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 01/2017
3	Glucose Intolerance 01/2021 - 01/2015
3	Hypophysitis 11/2020 - 07/2015
3	Disease Progression 11/2018 - 04/2014
3	Weight Gain 01/2018 - 02/2017
3	Hypovolemia 02/2006 - 07/2003
2	Headache (Headaches) 05/2024 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 01/2019
2	Infections 01/2023 - 05/2021
2	Pituitary Neoplasms (Pituitary Adenoma) 07/2022 - 07/2021
2	Latent Autoimmune Diabetes in Adults 01/2022 - 10/2021
2	Bulimia (Binge Eating) 01/2021 - 10/2019
2	Fibrosis (Cirrhosis) 01/2020 - 09/2010
2	Carcinogenesis 01/2020 - 07/2015
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2017
2	Autoimmune Hypophysitis 06/2017 - 07/2015
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2014 - 04/2010

Drug/Important Bio-Agent (IBA)

20	Vasopressins (Vasopressin)IBA 01/2024 - 03/2004
20	Arginine Vasopressin (Argipressin)IBA 03/2023 - 04/2004
13	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 08/2004
10	Insulin (Novolin)FDA Link 12/2023 - 03/2007
10	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2017
8	Messenger RNA (mRNA)IBA 09/2022 - 05/2009
6	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 02/2024 - 12/2010
6	AntibodiesIBA 01/2022 - 07/2015
5	NivolumabIBA 02/2024 - 03/2018
4	Streptozocin (Streptozotocin)FDA Link 12/2023 - 01/2015
4	Hormones (Hormone)IBA 01/2023 - 11/2017
4	LeptinIBA 01/2022 - 02/2012
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
4	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2010
3	SodiumIBA 02/2024 - 03/2016
3	Tolvaptan FDA Link 10/2023 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2020
3	LigandsIBA 01/2022 - 01/2017
3	CytokinesIBA 01/2020 - 04/2004
3	CarbohydratesIBA 03/2019 - 11/2017
3	SteroidsIBA 01/2019 - 11/2002
3	Rituximab (Mabthera)FDA Link 04/2014 - 01/2012
3	Immunoglobulin G (IgG)IBA 01/2013 - 11/2002
2	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2024 - 03/2018
2	Mutant Proteins (Protein, Mutant)IBA 01/2024 - 01/2018
2	ChemokinesIBA 12/2023 - 11/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2023 - 04/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023 - 01/2019
2	Aquaporin 2IBA 03/2023 - 11/2008
2	B7-H1 AntigenIBA 01/2022 - 05/2021
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2013
2	tazemetostatIBA 11/2021 - 01/2021
2	Pyruvic Acid (Pyruvate)IBA 10/2021 - 01/2021
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2021 - 11/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2012
2	AutoantigensIBA 11/2020 - 03/2018
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 07/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 02/2017
2	anagliptinIBA 01/2020 - 01/2020
2	Starch (Cornstarch)IBA 11/2017 - 07/2015
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2017 - 01/2016
2	GlucocorticoidsIBA 01/2017 - 10/2013
2	TabletsIBA 12/2016 - 01/2013
2	Minocycline (Cyclops)FDA LinkGeneric 11/2014 - 12/2010
2	fludarabineIBA 04/2014 - 01/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2014 - 12/2013
2	Vincristine (Oncovin)FDA LinkGeneric 12/2013 - 01/2011
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2013 - 10/2007
2	Amyloid (Amyloid Fibrils)IBA 01/2013 - 10/2010
2	Therapeutic UsesIBA 01/2013 - 10/2010

Therapy/Procedure

9	Therapeutics 01/2023 - 11/2002
6	Drug Therapy (Chemotherapy) 07/2021 - 04/2010
5	Glycemic Control 05/2024 - 01/2020
4	Transplantation 01/2023 - 04/2014
3	Aftercare (After-Treatment) 01/2022 - 01/2017
3	Immunotherapy 11/2021 - 01/2017
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 03/2021 - 01/2021
2	Infusion Pumps (Infusion Pump) 11/2014 - 12/2009
2	Combination Drug Therapy (Combination Chemotherapy) 04/2014 - 01/2012
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2012 - 01/2010